News and Media

Latest News Release
01/31/2024

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

New Cardinal Health research finds widespread acknowledgment of health inequities among oncologists
12/09/2022

DUBLIN, Ohio, Dec. 9, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) released today its latest edition of Oncology Insights, a biannual, research-based report from Cardinal Health. Featuring perspectives from nearly 200 oncologists nationwide, the 12th edition of Oncology Insights focuses on patient diversity, health equity in oncology, care management and symptom monitoring.

The research revealed that 80% of oncologists say inequities exist throughout healthcare, and nearly half say those inequities are especially prevalent in cancer care. "This research shows that despite advances in cancer treatment, patients from some groups still encounter more frequent and severe barriers to quality cancer care, including lack of access to the standard of care recommended for the type and stage of cancer with which they have been diagnosed," said Bruce Feinberg, DO, vice president, chief medical officer for Cardinal Health Specialty Solutions.

The study also found that 80% of oncologists say that health inequities lead to differences in care, including access to care and time to diagnosis and treatment. Nearly 60% say there is unconscious bias among U.S. healthcare providers toward non-white and Latinx patients. Almost half indicated that unconscious bias has adversely affected care for these patients.

"The widespread acknowledgment of inequities in oncology care is an encouraging sign that efforts to generate provider awareness are working," Feinberg said. "However, as a healthcare industry, we must keep working to improve access for patients through continued provider education and evidence-based initiatives that aim to deliver quality care to every patient, regardless of their background."

In addition to inequities in oncology care, the report also explores oncologists' perspectives on various care management services and the effectiveness of post-treatment follow-up tools. Key findings include:

  • Roughly three-fourths of oncologists say they would benefit from more research and education about healthcare inequities.
  • Most oncologists report being unfamiliar with chronic care management (CCM) and principal care management (PCM) services for Medicare beneficiaries with chronic conditions and eligibility criteria for patients with cancer.

The full report is available for download at cardinalhealth.com/oncologyinsights.

About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care facilities. With more than 50 years in business, operations in more than 30 countries and approximately 46,500 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.

Contacts
Media: To request a copy of the report, please contact Victoria Simmons, victoria.simmons@cardinalhealth.com.

SOURCE Cardinal Health

More Company News
07/23/2024

Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2024 on August 14, prior to the opening of trading on the New York Stock Exchange....

05/07/2024

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to its quarterly dividend, to $0.5056 per share, out of the Company's capital surplus. The dividend...

05/02/2024

Revenue increased 9% to $54.9 billion GAAP1 operating earnings were $367 million; GAAP diluted EPS was $1.05 Non-GAAP operating earnings increased 10% to $666 million; non-GAAP diluted EPS...

04/22/2024

Cardinal Health (NYSE: CAH) announced today that its pharmaceutical distribution contracts with OptumRx, which expire at the end of June 2024, will not be renewed. The company reaffirmed its...

View all company news »